Replies to post #114081 on Biotech Values

[sodrock]

Yes it sounded like they thought approval was imminent. You don't tell an account they will be getting patient discharge kits for posturing. I truly believe this minor deficiency letter caught them of guard. ONly time will tell if we will ever learn what's in that letter.

And to add to this.. When I first learned of the email back in July I was surprised TEVA would state such claims. I think it was desperation; and at that time and maybe even still now many TEVA drugs that this institution was using weren't and still aren't available because of manufacturing issues.

[10nisman]

The notion that Teva would give out information like this to potential customers as part of some sort of devious plot to hurt MNTA is verging on paranoid in my opinion.

Paranoid? Think about it... What is the worst thing that could have happened to Teva by telling potential tL customers that they expect approval soon? Nothing... Teva can call them up now and say whoops I guess the FDA was pulling our chain. It costs Teva nothing but it may have prevented NVS/MNTA from even higher uptake revenue. They would have been foolish to not have called potential customers and acted like they did.

10nis

[DewDiligence]

Sounds to me like Teva expected approval [in Jul 2010].

I highly doubt that.